# Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori

> **NCT03688828** · NA · COMPLETED · sponsor: **Huazhong University of Science and Technology** · enrollment: 360 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Saccharomyces boulardii
- **DRUG:** Esomeprazole
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin
- **DRUG:** Bismuth potassium citrate

## Key facts

- **NCT ID:** NCT03688828
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-11
- **Primary completion:** 2020-06-10
- **Final completion:** 2020-12-31
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2021-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688828, "Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03688828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*